Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Venom-Derived Bioactive Peptides: From Toxins to Therapeutics

Lookup NU author(s): Dr Othman AlmusaimiORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Abstract

Venoms are complex biochemical mixtures composed of diverse bioactive components, including proteins, enzymes, small molecules, and peptides. Among these, venom-derived peptides have been evolutionarily optimized to interact with biological targets with exceptional potency and selectivity. Although historically regarded solely as toxic substances, these peptides have increasingly been recognized as valuable templates for therapeutic development. This review examines the structural and biochemical properties of venom-derived peptides, as well as their molecular targets, with particular emphasis on their applications in pain management and cardiovascular disorders. Key milestones in venom-based drug discovery are highlighted, from the approval of captopril in 1981 to more recent peptide candidates such as Hi1a and leptucin. Despite notable successes, the clinical translation of venom peptides remains constrained by challenges related to their physicochemical properties, including stability, bioavailability, and delivery. Emerging strategies aimed at overcoming these limitations are also discussed, underscoring advances in peptide engineering and drug delivery technologies. Overall, this review highlights the significant therapeutic potential of venom-derived peptides and their expanding role in the development of novel treatments for a wide range of pathological conditions.

Publication metadata

Author(s): Sabu E, Al Musaimi O

Publication type: Article

Publication status: Published

Journal: Advanced Therapeutics

Year: 2026

Volume: 9

Issue: 8

Print publication date: 13/08/2026

Online publication date: 11/08/2026

Acceptance date: 08/08/2026

Date deposited: 26/08/2026

ISSN (electronic): 2366-3987

Publisher: Wiley-Blackwell Publishing Ltd.

URL: https://doi.org/10.1002/adtp.70166

DOI: 10.1002/adtp.70166

Data Access Statement: Data sharing not applicable to this article as no datasets were generated or analysed during the current study

Altmetrics

Altmetrics provided by Altmetric

Share